LZ–SMS treatment led to significant increases in the percentages of CD4+CD25+Foxp3+ Treg and IL-10+ Breg cells, together with a reduction in the plasma concentrations of several inflammatory cytokines and the down-regulated expression of the corresponding cytokine related genes in SLE mice. Here, IL10 is linked to systemic lupus erythematosus.